SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-19-010225
Filing Date
2019-07-03
Accepted
2019-07-03 12:38:24
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 42871
2 ex23-1.htm EX-23.1 4551
3 ex31-1.htm EX-31.1 19953
4 ex31-2.htm EX-31.2 20038
5 ex32.htm EX-32 10638
  Complete submission text file 0001493152-19-010225.txt   99354
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51353 | Film No.: 19940740
SIC: 7389 Services-Business Services, NEC